In a significant expansion of their longstanding collaboration, the partners hope to develop new models for delivering therapies to patients and provide full tuition to between 75 and 100 students each year for 10 years.
Telix Americas is leasing 10,000 square feet at the Crew CarWash headquarters building at 11700 Exit Five Parkway, near Interstate 69 and East 116th Street.
Any variant that winds up dominating in coming months will probably challenge a key line of treatment and protection for people with compromised immune systems—the drugs known as monoclonal antibodies.
The lawsuit was filed this month by a senior sales representative who worked for Eli Lilly for 11 years before resigning in June. The complaint seeks class-action status on behalf of thousand of employees and former employees of Lilly.
Indianapolis-based Eli Lilly and Co. announced Thursday that it has received a Fast Track designation from the U.S. Food and Drug Administration to investigate its diabetes drug tirzepatide for the treatment of adults with obesity.
Point Biopharma is moving aggressively to get its lead drug, a radioactive isotope called lutetium 177, through late-stage trials for prostate cancer.
The FDA approved the drug from Amylyx Pharmaceuticals based on results from one small, mid-stage study in which patients with the debilitating disease appeared to progress more slowly and survive several months longer.
The deal resolves allegations that the pharmaceutical maker violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs.
Researchers at Johns Hopkins University have found whether you’re standing upright or leaning, as well as which side you’re leaning to, could affect how fast the contents of a pill are absorbed into your body.
The FDA’s inspection was focused on production issues at a Bloomington-based plant operated by Catalent, which is helping to bottle and package Moderna’s COVID-19 vaccine.
Indianapolis-based biotech firm Point Biopharma Global Inc. hopes to raise about $125 million in the offering, before underwriting expenses and deductions.
City officials said Stevanato Group wants to increase its total investment in its Fishers plant to $512 million and its hiring plan to 515 employees. The facility is under construction near 126th Street and Cumberland Road.
The ruling Wednesday was a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year.
A review of prescription opioid medications, including their risks and contribution to the U.S. overdose epidemic, is still underway at the Food and Drug Administration, the agency’s commissioner said Tuesday.
In January, the cost of insulin for patients on Medicare will be capped at $35 a month. But that cap doesn’t apply to those with private insurance, which is used by the majority of those in need of insulin.
The researchers found that Paxlovid reduced hospitalizations among people 65 and older by roughly 75% when given shortly after infection. But people between the ages of 40 and 65 saw no measurable benefit, according to the analysis of medical records.
U.S. legislation requiring price negotiation for top-selling medicines will delay the launch of new drugs, AstraZeneca CEO Pascal Soriot warned.
The pharmaceutical giant continues to invest some of the cash influx reaped during the COVID-19 pandemic. The drugmaker has announced deals valued at a total of nearly $19 billion, counting debt, since late last year.
The cost to Indianapolis-based Eli Lilly and Co. would reach more than $183 million because cases brought under the False Claims Act triple the final judgment. Lilly said it plans to appeal and is confident that it will prevail.
Indianapolis-based Eli Lilly and Co. posted a profit of $1.13 billion, down from $1.68 billion a year ago, and cut its full-year profit guidance.
